Jeffrey Davidson joins Karmanos Cancer Institute Board of Directors

    NEXT STORY
    Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress
    PREV STORY
    Shire plc : 1st Quarter Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    DGAP-News: AiCuris celebrates its 10th Anniversary hosting a Mini-Symposium on Challenges and Breakthroughs of Anti-infective Therapies at the BIO-Europe(R) 2016

    DGAP-News: AiCuris Anti-infective Cures GmbH / Key word(s): Conference AiCuris celebrates its 10th Anniversary ...

    author_avatar
    NASDAQ Market News

    Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer

    author_avatar
    NASDAQ Market News

    Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617

    -Publication includes analysis of original 30 patients previously presented at 2017 ESMO by Professor ...

    author_avatar
    NASDAQ Market News